Dr. Leland Metheny, MD
Claim this profileUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Studies Acute Lymphoblastic Leukemia
Studies Multiple Myeloma
12 reported clinical trials
23 drugs studied
Area of expertise
1Acute Lymphoblastic Leukemia
CD22 positive
Philadelphia chromosome positive
2Multiple Myeloma
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Leland Metheny, MD is currently running
Inotuzumab Ozogamicin Post-Transplant
for Leukemia and Lymphoma
This study has two phases, Phase I and Phase II. The main goal of the Phase I portion of this research study is to see what doses post-transplant inotuzumab ozogamicin can safely be given to subjects without having too many side effects. The Phase II portion of this study is to see what side effects are seen with medication after transplant. Inotuzumab ozogamicin is a combination of an antibody and chemotherapy which has been shown to have significant activity against relapsed/refractory acute lymphocytic leukemia (ALL). Inotuzumab ozogamicin is considered experimental in this study.
Recruiting1 award Phase 1 & 2
Abatacept
for Leukemia
The goal of this clinical trial is to see if adding abatacept to tacrolimus and MMF prevents or reduces the chances of acute graft versus host disease which is a complication that can occur after transplant in participants with blood cancer. The usual therapy for graft versus host disease prevention after a cord blood transplant includes tacrolimus and MMF. The main question this clinical trial aims to answer is whether or not abatacept will be safe and effective in reducing aGVHD rates in dCBT. Participants will: * Partake in exams, tests, and procedures as part of usual cancer care. * Partake in conditioning, which is the treatment that is given before a transplant. * Have a cord blood transplant. * Partake in radiation following the transplant.
Recruiting1 award Phase 24 criteria
More about Leland Metheny, MD
Clinical Trial Related8 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Leland Metheny, MD has experience with
- Lenalidomide
- Carmustine
- Filgrastim
- O6-benzylguanine
- P140K-MGMT
- Photon Based Radiotherapy
Breakdown of trials Leland Metheny, MD has run
Acute Lymphoblastic Leukemia
Multiple Myeloma
Myelodysplastic Syndrome
Central Nervous System Hodgkin Lymphoma
Acute Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Leland Metheny, MD specialize in?
Leland Metheny, MD focuses on Acute Lymphoblastic Leukemia and Multiple Myeloma. In particular, much of their work with Acute Lymphoblastic Leukemia has involved CD22 positive patients, or patients who are Philadelphia chromosome positive.
Is Leland Metheny, MD currently recruiting for clinical trials?
Yes, Leland Metheny, MD is currently recruiting for 7 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Leland Metheny, MD has studied deeply?
Yes, Leland Metheny, MD has studied treatments such as Lenalidomide, Carmustine, Filgrastim.
What is the best way to schedule an appointment with Leland Metheny, MD?
Apply for one of the trials that Leland Metheny, MD is conducting.
What is the office address of Leland Metheny, MD?
The office of Leland Metheny, MD is located at: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio 44106-5065 United States. This is the address for their practice at the University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.